1. Home
  2. IPSC vs AIRE Comparison

IPSC vs AIRE Comparison

Compare IPSC & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

58.3M

Sector

Health Care

ML Signal

HOLD

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$0.46

Market Cap

56.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
AIRE
Founded
2019
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.3M
56.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPSC
AIRE
Price
$0.92
$0.46
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$3.00
$2.00
AVG Volume (30 Days)
1.5M
6.1M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$113,337,000.00
$4,149,567.00
Revenue This Year
$1,590.09
$456.19
Revenue Next Year
N/A
$105.16
P/E Ratio
N/A
N/A
Revenue Growth
4122.69
994.18
52 Week Low
$0.34
$0.14
52 Week High
$1.19
$2.29

Technical Indicators

Market Signals
Indicator
IPSC
AIRE
Relative Strength Index (RSI) 61.52 46.96
Support Level $0.91 $0.40
Resistance Level $1.05 $0.60
Average True Range (ATR) 0.12 0.04
MACD 0.01 0.00
Stochastic Oscillator 66.72 27.74

Price Performance

Historical Comparison
IPSC
AIRE

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

Share on Social Networks: